Sanara MedTech (SMTI) Equity Average (2011 - 2026)

Sanara MedTech (SMTI) has 13 years of Equity Average data on file, last reported at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 82.85% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (down 82.85% YoY), and the FY2025 full-year result was $22.4 million, down 46.3% from the prior year.
• Equity Average for Q1 2026 stood at $6.5 million, up from $6.0 million in the prior quarter.
• Across five years, Equity Average topped out at $44.3 million in Q4 2023 and bottomed at $6.0 million in Q4 2025.
• The 5-year median for Equity Average is $40.4 million (2024), against an average of $34.8 million.
• The widest annual swing landed in 2022, when Equity Average surged 42.01%; it then sank 84.59% in 2025.
• A 5-year view of Equity Average shows it stood at $43.2 million in 2022, then increased by 2.68% to $44.3 million in 2023, then dropped by 11.64% to $39.2 million in 2024, then tumbled by 84.59% to $6.0 million in 2025, then rose by 7.28% to $6.5 million in 2026.
• The last three Equity Average figures came in at $6.5 million (Q1 2026), $6.0 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.

Peer Comparison